Protein analysis: Clinical Trials

22 trials of Protein analysis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 6 unknown, 2 terminated, 1 recruiting. 6 Phase 2, 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 2, Unknown 2, Terminated 1, Withdrawn 1
Early Phase 11Completed 1
Phase 11Withdrawn 1

Follow Protein analysis: new trials by email Literature Review of Protein analysis trials Research Report on Protein analysis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dysferlinopathy Protein in Peripheral Blood Monocytes.
Protein analysis - Muscular Dystrophies, Limb-Girdle Muscular Dystrophy Type 2B
CompletedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1492012-02-012024-07-18
Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia
mutation analysis, protein analysis, laboratory biomarker analysis - Leukemia
CompletedEastern Cooperative Oncology Group2202012-01-032017-05-19
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma
fluorescence in situ hybridization, gene expression analysis, microarray analysis - Neuroblastoma
CompletedChildren's Oncology Group52011-12-012016-07-11
Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia
gene expression analysis, gene rearrangement analysis, polymerase chain reaction - Leukemia
CompletedChildren's Oncology Group202011-12-012016-05-18
Biomarker in Tissue Samples From Patients With Ewing Sarcoma
microarray analysis, protein analysis, immunohistochemistry staining method - Sarcoma
CompletedChildren's Oncology Group402011-05-012016-07-11
Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy
fluorescence in situ hybridization, gene expression analysis, polymerase chain reaction - Head and Neck Cancer
CompletedECOG-ACRIN Cancer Research Group692010-08-052017-05-17
Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma
defined green tea catechin extract, gene expression analysis, protein analysis - Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition
Phase 2TerminatedBarbara Ann Karmanos Cancer Institute82009-11-012015-03-27
Fatigue in Breast Cancer Survivors
protein analysis, laboratory biomarker analysis, mass spectrometry - Breast Cancer, Cancer Survivor
UnknownSt George's, University of London962009-01-012013-08-26
Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer
cyclosporine, mycophenolate mofetil, pentostatin - Chronic Myeloproliferative Disorders, Leukemia
Phase 1 / Phase 2WithdrawnUniversity of Nebraska2008-09-012023-08-14
Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy
erlotinib hydrochloride, sorafenib tosylate, DNA analysis - Lung Cancer
Phase 2UnknownYonsei University472008-09-012009-08-25
Study of Bone Marrow Samples From Patients With Acute Leukemia
gene expression analysis, mutation analysis, polymorphism analysis - Leukemia
CompletedEastern Cooperative Oncology Group402008-07-032017-05-17
Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy Volunteers
DNA analysis, polymorphism analysis, protein analysis - Breast Cancer
UnknownQueen Mary University of London60002008-07-012013-08-12
Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
bortezomib, dexamethasone, pegylated liposomal doxorubicin hydrochloride - Multiple Myeloma and Plasma Cell Neoplasm
Phase 2UnknownOncotherapeutics352008-07-012013-12-18
Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery
erlotinib hydrochloride, protein analysis, western blotting - Head and Neck Cancer
Early Phase 1CompletedWake Forest University Health Sciences242008-03-012018-07-05
Studying Biomarkers in Patients With Pancreatic Cancer
protein analysis, laboratory biomarker analysis - Pancreatic Cancer
CompletedVanderbilt-Ingram Cancer Center532007-05-012013-12-12
Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery
chemotherapy, endocrine therapy, DNA methylation analysis - Breast Cancer
CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins352006-05-012015-10-12
Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors
capecitabine, cisplatin, streptozocin - Gastrointestinal Carcinoid Tumor, Islet Cell Tumor
Phase 2CompletedCambridge University Hospitals NHS Foundation Trust842005-08-012013-08-07
Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma
everolimus, DNA analysis, protein analysis - Multiple Myeloma and Plasma Cell Neoplasm
Phase 2CompletedMayo Clinic352005-03-012011-05-16
Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer
DNA analysis, RNA analysis, microarray analysis - Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer
UnknownCancer Research UK40002002-08-012013-08-12
Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer
gene expression analysis, protein analysis, biologic sample preservation procedure - Prostate Cancer
UnknownCancer Research UK2002-01-012013-08-12

Showing 20 of 22. Sign in to see all of them.

Conditions studied

Breast Neoplasms (4)  ·  Leukemia (4)  ·  Multiple Myeloma (4)  ·  Leukemia, Myeloid, Acute (3)  ·  Neoplasms, Plasma Cell (3)  ·  Carcinoma, Intraductal, Noninfiltrating (2)  ·  Congenital Abnormalities (2)  ·  Head and Neck Neoplasms (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Adenocarcinoma Of Esophagus (1)  ·  Adenoma, Islet Cell (1)  ·  Anemia, Aplastic (1)  ·  Blast Crisis (1)  ·  Breast Carcinoma In Situ (1)  ·  Carcinoma, Islet Cell (1)

Sponsors

Children's Oncology Group (3)  ·  Cancer Research UK (2)  ·  Eastern Cooperative Oncology Group (2)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  Boston Medical Center (1)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  City of Hope Medical Center (1)  ·  ECOG-ACRIN Cancer Research Group (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  Mayo Clinic (1)  ·  Oncotherapeutics (1)  ·  Queen Mary University of London (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)  ·  St George's, University of London (1)  ·  University of Nebraska (1)

Countries

United States (7)  ·  United Kingdom (5)  ·  South Korea (1)  ·  Spain (1)

Top investigators

A. Bapsi Chakravarthy, MD (1)  ·  Carlos Caldas (1)  ·  Courtney DiNardo, MD (1)  ·  David Neil, MD (1)  ·  Elinor Sawyer, MD (1)  ·  J. D. Browne, MD (1)  ·  James R. Berenson, MD (1)  ·  Jeffrey A. Zonder, MD (1)  ·  Jennifer R. Grandis, MD (1)  ·  John Crispino, PhD (1)  ·  John Yim, MD (1)  ·  Joo-Hang Kim, MD (1)  ·  Joshua D. Schiffman, MD (1)  ·  Julie D. Saba, MD, PhD (1)  ·  Mercedes Porosnicu, MD (1)

Results publications

PMID 22733017, PMID 26898607, PMID 27460276, PMID 30333122, PMID 31306033, PMID 32130406, PMID 36110959, PMID 40526008

NIH funding

P30CA006973 (1), P30CA012197 (1), P30CA015083 (1), P30CA022453 (1), P30CA033572 (1), P30CA036727 (1), P30CA068485 (1)